Michał Mikuła

4.3k total citations
135 papers, 2.7k citations indexed

About

Michał Mikuła is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michał Mikuła has authored 135 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 34 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Michał Mikuła's work include RNA Research and Splicing (14 papers), RNA modifications and cancer (12 papers) and Gut microbiota and health (12 papers). Michał Mikuła is often cited by papers focused on RNA Research and Splicing (14 papers), RNA modifications and cancer (12 papers) and Gut microbiota and health (12 papers). Michał Mikuła collaborates with scholars based in Poland, United States and Hungary. Michał Mikuła's co-authors include Jerzy Ostrowski, Agnieszka Paziewska, Tymon Rubel, Krzysztof Goryca, Jakub Karczmarski, Maria Kulecka, Artur Dzwonek, Michał Dadlez, Karol Bomsztyk and Dorota Jarosz and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Michał Mikuła

126 papers receiving 2.7k citations

Peers

Michał Mikuła
Anthony W. Ashton United States
Amar B. Singh United States
Xin Yan China
Nengtai Ouyang United States
Michał Mikuła
Citations per year, relative to Michał Mikuła Michał Mikuła (= 1×) peers Amelia Casamassimi

Countries citing papers authored by Michał Mikuła

Since Specialization
Citations

This map shows the geographic impact of Michał Mikuła's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Mikuła with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Mikuła more than expected).

Fields of papers citing papers by Michał Mikuła

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Mikuła. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Mikuła. The network helps show where Michał Mikuła may publish in the future.

Co-authorship network of co-authors of Michał Mikuła

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Mikuła. A scholar is included among the top collaborators of Michał Mikuła based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Mikuła. Michał Mikuła is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mikuła, Michał, et al.. (2025). Genetically Modified Mouse Models for Sarcoma Research: A Comprehensive Review. Current Oncology Reports. 27(11). 1221–1248.
2.
Earnshaw, David L., Ewelina Kaniuga, Małgorzata Statkiewicz, et al.. (2024). Therapeutic Responses to Two New SN-38 Derivatives in Colorectal Cancer Patient-Derived Xenografts and Respective 3DIn VitroCultures. Anticancer Research. 44(10). 4219–4224. 1 indexed citations
3.
Sas, Zuzanna, Maria Kulecka, Katarzyna Piwocka, et al.. (2024). Iron‐triggered signaling via ETS1 and the p38/JNK MAPK pathway regulates Bmp6 expression. American Journal of Hematology. 99(4). 543–554. 4 indexed citations
4.
Kołat, Damian, Arkadiusz Gajek, Elżbieta Płuciennik, et al.. (2024). Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors. Cells. 13(10). 867–867. 2 indexed citations
5.
Brzozowska, B., et al.. (2024). The Risk Function of Breast and Ovarian Cancers in the Avrami–Dobrzyński Cellular Phase-Transition Model. International Journal of Molecular Sciences. 25(2). 1352–1352. 1 indexed citations
6.
Statkiewicz, Małgorzata, Arkadiusz Gajek, Izabela Szymczak-Pajor, et al.. (2024). Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian cancer models. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(2). 167574–167574. 2 indexed citations
7.
Macias, Matylda, Aleksandra Szybińska, Michał Mikuła, et al.. (2023). Impaired iron recycling from erythrocytes is an early hallmark of aging. eLife. 12. 20 indexed citations
8.
Kolmus, Krzysztof, Krzysztof Goryca, Anna Szumera‐Ciećkiewicz, et al.. (2021). Concurrent depletion of Vps37 proteins evokes ESCRT-I destabilization and profound cellular stress responses. Journal of Cell Science. 134(1). 16 indexed citations
9.
Bakuła‐Zalewska, Elwira, Krzysztof Goryca, Agnieszka Paziewska, et al.. (2021). Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma. Journal of Clinical Medicine. 10(11). 2304–2304. 4 indexed citations
10.
Paszkiewicz‐Kozik, Ewa, Agnieszka Paziewska, Maria Kulecka, et al.. (2021). Peripheral Blood Cells from Patients with Hodgkin’s and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs. BioMed Research International. 2021(1). 3212878–3212878.
11.
Starzyñska, Teresa, Jakub Karczmarski, Agnieszka Paziewska, et al.. (2020). Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. International Journal of Molecular Sciences. 21(12). 4470–4470. 12 indexed citations
12.
Gajek, Arkadiusz, Agnieszka Marczak, Michał Mikuła, et al.. (2020). PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. International Journal of Molecular Sciences. 21(24). 9715–9715. 29 indexed citations
13.
Ambrożkiewicz, Filip, Jakub Karczmarski, Maria Kulecka, et al.. (2020). Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues. BioMed Research International. 2020(1). 9086829–9086829. 12 indexed citations
14.
Podkalicka, Paulina, Olga Mucha, Magdalena Kozakowska, et al.. (2020). Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight. 5(11). 27 indexed citations
15.
Kulecka, Maria, Barbara Frączek, Michał Mikuła, et al.. (2020). The composition and richness of the gut microbiota differentiate the top Polish endurance athletes from sedentary controls. Gut Microbes. 11(5). 1374–1384. 73 indexed citations
16.
Rudzińska, Magdalena, et al.. (2019). Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination. International Journal of Molecular Sciences. 20(22). 5619–5619. 18 indexed citations
17.
Konieczny, Piotr, Agata Lichawska-Cieślar, Joanna Cichy, et al.. (2019). Keratinocyte-specific ablation of Mcpip1 impairs skin integrity and promotes local and systemic inflammation. Journal of Molecular Medicine. 97(12). 1669–1684. 18 indexed citations
18.
Rudzińska, Magdalena, Anna Stachurska, Michał Mikuła, et al.. (2019). Molecular Signature of Prospero Homeobox 1 (PROX1) in Follicular Thyroid Carcinoma Cells. International Journal of Molecular Sciences. 20(9). 2212–2212. 8 indexed citations
19.
Lichawska-Cieślar, Agata, Maria Kulecka, Agnieszka Paziewska, et al.. (2018). RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line. Oncotarget. 9(9). 8597–8613. 19 indexed citations
20.
Mikuła, Michał, et al.. (1990). Isolation of Listeria from brains of ruminants with suspected rabies.. Wiener Tierarztliche Monatsschrift. 77(9). 291–296. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026